Innovative Surgical Solutions Zyga specializes in minimally invasive surgical devices targeting underserved spine conditions such as facetogenic and sacroiliac joint pain, representing an opportunity to introduce their products to hospitals and clinics looking for effective treatment options.

Growing Market Presence With recent clinical study milestones and product launches, Zyga is expanding its footprint in the spine treatment market, making it a promising target for partnerships with healthcare providers seeking innovative devices.

Acquisition and Investment Support Having been acquired by RTI Surgical in 2018 and supported by a $20M funding round in 2015, Zyga demonstrates strong backing, which can be leveraged to approach larger healthcare organizations and investors interested in spine innovation.

Focused Product Development The company’s development of the Glyder Facet Restoration Device and ongoing clinical studies reflect a commitment to advancing minimally invasive spine solutions, offering sales opportunities through clinical pathways and specialized surgical centers.

Market Penetration Opportunities Given the company's relatively small size with 11-50 employees and a revenue under $1M, there is potential for growth through strategic partnerships, distribution channels, and targeted outreach to expanding healthcare networks and spine specialists.